RxDoctor Payments Data

Jacinto Camarena, MD

Vascular & Interventional Radiology · Decatur, GANPI 1790791804

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,493 of the $6,390 with a category attached, or 86.0%. It is spread thinly across 21 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,086 and has fallen 72.3% since, to $579 in 2025.

$6,390in general payments, 2019–2025

Across 83 payments — averaging $76.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$1K
  • Abbott$1K
  • Medtronic$870
  • Boston Scientific$538
  • Sirtex Medical Inc$480
  • Surmodics, Inc.$440
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$89714%
  • Food & beverage$5,49386%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,390 in reported general payments places this provider in the 65th percentile of 120 vascular & interventional radiology providers in Georgia.

See all vascular & interventional radiology providers in Georgia

Medicare billing

Part B allowed, 2024
$348,274
Medicare patients
292
Services billed
1,049

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate13$96

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →